|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 132.72 USD | -0.00% |
|
+0.02% | +75.83% |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| 06-25 | Apogee Therapeutics Insider Sold Shares Worth $3,500,640, According to a Recent SEC Filing | MT |
| Market Cap | 9.95B 8.73B 8.04B 7.49B 14.13B 946B 14.42B 96.7B 37.46B 464B 37.35B 36.54B 1,616B | P/E 2026 * |
-30.8x | P/E 2027 * | -23.8x |
|---|---|---|---|---|---|
| Enterprise Value | 8.97B 7.87B 7.25B 6.75B 12.74B 853B 13B 87.17B 33.78B 419B 33.67B 32.95B 1,457B | EV / Sales 2026 * |
987x | EV / Sales 2027 * | 737x |
| Free-Float |
87.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Apogee Therapeutics, Inc.
| 1 week | +0.02% | ||
| Current month | -0.01% | ||
| 1 month | +67.36% | ||
| 3 months | +57.55% | ||
| 6 months | +75.14% | ||
| Current year | +75.83% |
| 1 week | 132.55 |  | 132.89 |
| 1 month | 77.1 | | 133.16 |
| Current year | 60.35 | | 133.16 |
| 1 year | 34.34 | | 133.16 |
| 3 years | 14.19 | | 133.16 |
| 5 years | 14.19 | | 133.16 |
| 10 years | 14.19 | | 133.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 36 | 01/09/2022 | |
Jane Henderson
DFI | Director of Finance/CFO | 60 | 01/01/2023 |
Tim Piringer
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jennifer Fox
BRD | Director/Board Member | 54 | 22/06/2023 |
William Jones
BRD | Director/Board Member | 62 | 01/06/2023 |
| Director/Board Member | 36 | 01/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Sell | Chief Executive Officer | -80,000 | 0.1429% | ||
| 06-22 | Sell | Chief Technology Officer | -26,400 | 0.0471% | ||
| 06-10 | Sell | Chief Executive Officer | -20,000 | 0.0357% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.00% | +0.02% | +199.86% | - | 9.95B | |
| +3.08% | +6.47% | -0.25% | +6.27% | 47.18B | |
| -0.84% | +9.34% | +403.17% | +591.84% | 39.82B | |
| +5.04% | +9.44% | +24.93% | -8.11% | 32.25B | |
| +2.32% | +5.22% | +18.94% | +61.23% | 31.68B | |
| +0.69% | +8.72% | +14.80% | +30.86% | 24.59B | |
| -0.16% | +11.73% | - | - | 16.57B | |
| +3.19% | +6.21% | +69.63% | +127.83% | 15.12B | |
| -0.15% | +2.15% | +12.64% | +17.55% | 13.69B | |
| -0.98% | +2.59% | +96.54% | +91.09% | 13.1B | |
| Average | +1.16% | +6.62% | +93.36% | +114.82% | 24.39B | |
| Weighted average by Cap. | +1.55% | +7.10% | +98.02% | +136.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.09M 7.98M 7.35M 6.85M 12.91M 864M 13.17M 88.37M 34.24M 424M 34.13M 33.4M 1.48B | 12.5M 10.98M 10.1M 9.41M 17.75M 1.19B 18.11M 122M 47.08M 583M 46.93M 45.92M 2.03B |
| Net income | -318M -279M -257M -239M -451M -30.19B -460M -3.09B -1.2B -14.82B -1.19B -1.17B -51.57B | -416M -366M -337M -314M -591M -39.59B -603M -4.05B -1.57B -19.43B -1.56B -1.53B -67.64B |
| Net Debt | -980M -860M -792M -738M -1.39B -93.12B -1.42B -9.52B -3.69B -45.71B -3.68B -3.6B -159B | -740M -650M -598M -557M -1.05B -70.38B -1.07B -7.2B -2.79B -34.54B -2.78B -2.72B -120B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/07/26 | $132.73 | -0.00% | 2,221,988 |
| 30/06/26 | $132.73 | +0.09% | 5,436,413 |
| 29/06/26 | $132.61 | +0.05% | 3,494,734 |
| 26/06/26 | $132.55 | -0.10% | 5,109,502 |
| 25/06/26 | $132.68 | -0.01% | 4,952,655 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- APGE Stock
Select your edition
All financial news and data tailored to specific country editions
